Want to create an interactive transcript for this episode?
Podcast: The Alldus Podcast - AI in Action
Episode: E413 Rachel Liberatore, President & Chief Scientific Officer at RenBio
Description: Today's guest is Rachel Liberatore, President & Chief Scientific Officer at RenBio in New York. RenBio was founded in 1996 on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone. RenBio's goal is to deliver antiviral antibodies to prevent the spread of infectious diseases, and improve the dosing regimen and effectiveness of therapeutic proteins.
Using RenBio’s Make Your Own (MYO) Technology, therapeutic-encoding “bioblueprints” are delivered via modified intramuscular injection, which are then decoded by the muscle cells to produce disease-fighting therapeutics in the patient’s own body. Their vision is to modernize and trans...